The novel therapy of tirzepatide peptide represents a significant breakthrough in the management of the condition. Different to existing therapies, tirzepatide impacts multiple pathways – the GLP-1 hormone and glucose-dependent insulinotropic polypeptide (GIP) – providing greater sugar regulation and anticipated weight reduction. Experts are ex